Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a rapid, reliable and widely used method of studying gene expression profiles that requires appropriate normalization for accurate and reliable results. Reference genes are usually used to normalize mRNA levels; however, the expression levels of these reference genes may vary between cell types, developmental stages, species and experimental conditions. Therefore, a normalization strategy is an important precondition for reliable conclusions, with endogenous controls requiring determination for every experimental system. In the present study, 18 reference genes used in various prior studies were analyzed to determine their applicability in bladder cancer. A total of 35 matched malignant and non-malignant bladder cancer (specifically transitional cell carcinoma) tissue specimens were examined. RNA and cDNA quality was stringently controlled. Candidate reference genes were assessed using SYBR-Green RT-qPCR. mRNA abundance was compared and reference genes with distinct ranges of expression to possible target genes were excluded. Genes that were differentially expressed in matched non-cancerous and cancerous samples were also excluded, using quantification cycle analysis. Subsequently, the stability of the selected reference genes was analyzed using three different methods: geNorm, NormFinder and BestKeeper. The rarely used ribosomal protein S23 (RPS23) was the most stable single reference gene, with RPS23, tumor protein, translationally controlled 1 and RPS13 comprising the optimal reference gene set for all the bladder samples. These stable reference genes should be employed in normalization and quantification of transcript levels in future expression studies of bladder cancer-associated genes.
Introduction
Bladder cancer, a disease that is reported more frequently in men than in women, is the most common urological malignancy (1) . It has been estimated that there were ~74,000 novel cases and 16,000 incidences of mortality in the USA alone in 2015 (2) . In total, ~90% of these patients were diagnosed with transitional cell carcinoma (TCC), whereas adenocarcinoma and squamous cell carcinoma accounted for <10% of the cases (3) . TCC is one of only a limited number of types of cancer that is responsive to immunotherapy (4) . Bladder cancer has a high probability of recurrence, which makes it a costly cancer to treat (5) . To develop an effective and cost-effective therapy for TCC, it is necessary to identify and exploit the molecular mechanisms and factors involved (6) , particularly the markers of recurrent disease.
Comparing the level of certain mRNAs in cancer tissues with the same patents' normal tissues is a practical approach to identifying new biomarkers implicated in the TCC process.
Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction
In order to do this, fluorescence-based reverse transcription-quantitative polymerase chain reaction (RT-qPCR), which is one of the most common and powerful quantification methods, was employed in the present study to evaluate mRNA expression in specimens affected by bladder cancer. The result obtained by RT-qPCR not only informs on the cancer-driven biological variation of gene expression, but also reflects the confounding factors as well. According to The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (7), these factors are associated with the entire procedure of qPCR, from experimental design to data analysis. Therefore, the choice of reference genes is one of the most influential factors in RT-qPCR, because these genes can be applied to a normalization strategy to monitor the variation in amplification efficiencies as well as the differences between the samples, particularly for cancer tissues (8) .
Reference genes, such as the housekeeping genes GAPDH and β-actin, are usually constitutively expressed at high levels in different cell types or tissues, but their mRNA levels may be affected by the cell type or tissue used, as well as the experimental conditions (9, 10) . Thus, it is of critical importance to evaluate the reference genes under similar experimental conditions in the same tissue type prior to their use normalizing RNA levels for target genes. Several freely available mathematical software programs, including geNorm (11) , NormFinder (12) and BestKeeper (13) , have been developed to address this issue.
Despite the fact that the selection of a reference gene is important, the majority of published gene expression reports do not state the rationale for the selection made (14) . As a result, numerous studies of gene expression often fail to produce comparable and reliable results. RT-qPCR with SYBR-Green is widely used in a number of studies investigating cancer, but few have reported the expression stability of reference genes in bladder cancer (12, 15) . One study reportedly employed SYBR-Green chemistry (12) , but it was performed without any matched non-cancerous samples and used different mathematical algorithms from those in the present study. Therefore, the present study sought to identity the most suitable reference genes for mRNA profiling in bladder cancer, specifically TCC. To this end, 18 carefully selected reference genes were quantified using SYBR-Green qPCR, then the expression stability of the candidate genes was evaluated using quantification cycle (Cq) analysis, geNorm, NormFinder and BestKeeper.
Materials and methods
Human TCC sample collection. The inclusion criteria were as follows: Patients newly diagnosed with TCC for whom tumors were removed by transurethral resection and patients with adequately matched non-cancerous TCC samples. Exclusion criteria included non-TCC histology, salvage cystectomy, upper tract TCC and incomplete medical records. Written informed consent was obtained from all patients and the present study was approved by the Sun Yat-Sen University Cancer Center (Guangzhou, China) and the institutional review board of Shenzhen Second People's Hospital (Shenzhen, China). A total of 35 fresh tumor samples with matched normal controls (morphologically adjacent normal bladder tissues) were obtained from individuals newly diagnosed with TCC from June 2013 to October 2014 (Table I) . Patients were aged between 41 and 81 years, with a mean age of 61 years. The samples were divided into two groups: One group was used for conventional pathology examination analysis in the pathology department of the hospital, whereas the second was immediately immersed in RNAlater (Qiagen GmbH, Hilden, Germany) and stored at -80˚C or snap-frozen in liquid nitrogen until RNA extraction.
Total RNA isolation and cDNA synthesis. The preserved TCC samples (18-70 mg) were cut into the smallest possible pieces and homogenized in 200 µl TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) under sterile conditions. Total RNA was then extracted according to the manufacturer's protocol. The quantification and quality control of total RNA were performed in triplicate with a NanoDrop2000 spectrophotometer (Thermo Fisher Scientific, Inc.). According to the MIQE guidelines, the following conditions must be met for cDNA synthesis: An RNA concentration >50 ng/µl and absorbance ratios of 260/280 nm of between 1.8 and 2.1. The integrity and genomic DNA contaminant of isolated RNA was In a 20 µl PCR, 1 µg of Total RNA was reverse-transcribed into first-strand cDNA using PrimeScript RT Master Mix (Takara Bio, Inc., Otsu, Japan). The reaction mixture was incubated at 37˚C for 15 min for RT, then at 85˚C for 5 sec to inactivate reverse transcriptase. The RT products were subsequently stored at -20˚C until further use. The PrimeScript RT Master mix included reaction buffer (Mg 2+ ), PrimeScript reverse transcriptase, dNTP mixture, random hexamers, oligo dT primer and an RNase inhibitor, used to ensure the uniformity of the reverse transcription reaction between samples. cDNAs of all samples were diluted 1:10 for qRT-PCR.
Selection of the candidate reference genes and validation of the primers.
A total of 18 candidate reference genes were selected in the present study. Their identity and characteristics are summarized in Table II , including the gene name, GenBank accession number and the sequence of primer pairs.
The primers were synthesized by Sangon Biotech Co., Ltd (Shanghai, China). They were selected on the basis of published reports on reference gene expression profiles and previous databases (11) (12) (13) (14) (15) (16) . Next, the primer sequences were cross-checked using the University of California Santa Cruz web-based tool in silico PCR (genome.ucsc.edu/cgi-bin/hgPcr) (17) against genomic and gene targets. qPCR was performed on cDNA of randomly selected tumor tissues to check the specificity of all primers. The melting curve and the visualized PCR products on 2% SYBR-Green-safe agarose gel were then evaluated ( Fig. 1) .
RT-qPCR. RT-qPCR for 18 candidate reference genes was performed in 96-well plates with the LightCycler 480 Real-Time PCR System (Roche Applied Science, Pleasanton, CA, USA) and qTOWER2.0 (Analytik Jena AG, Jena, Germany). A LightCycler 480 SYBR Master (Roche Applied Science) was used to detect double-stranded DNA synthesis. In a 10 µl total volume, the PCRs contained 5 µl Premix Ex Taq (Roche Applied Science), 1 µl 10-fold diluted RT product (50 ng total RNA), 1 µl forward and 1 µl reverse PCR primers (300 nM; Sangon Biotech Co., Ltd) and 2 µl nuclease-free water (Roche Applied Science). The reaction mixtures were processed with an initial holding period at 95˚C for 10 min, followed by a three-step PCR program for 45 cycles that consisted of 95˚C for 10 sec, 60˚C for 10 sec and 72˚C for 25 sec. Immediately following PCR, a melting curve program was activated by heating the product from 65-95˚C at 0.1˚C intervals. Reverse transcriptase negative controls and no-template controls (NTC) were also included in each experiment to avoid the contamination of genomic DNA or primer dimers. Cancerous and corresponding non-cancerous specimens were processed in the same run to exclude between-run variations. The results of the melting curve analysis and electrophoresis of the PCR products were used to confirm the specificity of the amplification for each of the primer pairs (Fig. 1) .
Cq value calculation and PCR efficiency. The Cq value is equal to the number of cycles at which the value of the fluorescent signal reaches a given threshold of detection, and this value is negatively associated with the initial amount of the input Yes mRNA (8, 18) . In the present study, the Cq value was adjusted to 0.1 in order to compare different qPCRs on different plates, runs and days. Values were excluded from further study when the Cq value was >40. The gene-specific PCR efficiency of the primers were calculated from the standard curves, which were constructed using the following method: cDNA was diluted (19) . A paired Student's t-test, used to compare numerical data between the matched non-malignant and malignant specimens, was performed using GraphPad Prism (version 5.1; GraphPad, Inc., La Jolla, CA, USA). The correlation coefficients (R 2 ) of each primer pair were calculated from the standard curves. The coefficient of correlation (R) demonstrated gene expression variation and was determined by calculating the coefficient of variance and standard deviation of the Cq set using BestKeeper analysis (version 1.0; http://www.gene-quantification.de/bestkeeper.html).
Results
Specificity and efficiency of the primers for the 18 candidate reference genes. Melting curve analysis and agarose gel electrophoresis gave a single expected product for each selected gene (Fig. 1) . No primer dimers or non-specific PCR products were detected in the NTC, and there were no evident genomic DNA contamination, as evidenced by the negative result obtained using the reverse transcriptase negative control.
The RT-qPCR efficiency of the primers was determined using a dilution of 1:10 of the cDNA template from a randomly selected human TCC sample. RNA levels may vary in the course of reverse transcription, so a randomly selected sample was selected rather than a plasmid (20) (21) (22) (23) . All the PCR assays produced efficiency values for each gene, which ranged between 1.97 and 2.15, with a slope from -3.045 to -3.392, intercept from 26.354 to 31.279 and R 2 from 0.994 to 0.999 (Table ΙΙΙ) .
Expression levels of 18 candidate reference genes. A total of 18 candidate reference genes were selected, involved in different pathways and functions, to avoid even the slightest deviation in co-regulation (11) . Two cases [ribosome protein S13 (RPS13) and RPS23, ubiquitin B (UBB) and UBC] had similar functions, but were located on different chromosomes (Table I) and 24 included the majority of the candidate reference genes. Genes with lower expression levels had higher Cq values. Above 25 cycles, these genes were succinate dehydrogenase complex flavoprotein subunit A (SDHA), TATA box-binding protein (TBP), HPRT1 and RNA polymerase II subunit A (POLR2A). The remaining 14 candidate reference genes were highly expressed below 25 cycles. The expression levels of the 18 candidate reference genes did not depend on the sex, age, tumor stage or grade of the TCC samples. This result was consistent with the results of a previous study (17) .
An ideal reference gene is required to meet the following criteria: i) Is usually abundant in studied tissues that can be reliably examined in all specimens; and ii) exhibits as little as possible expression variation across the tissue-specific sample set investigated. For the first criterion, genes with Cq values >25 cycles were arbitrarily selected for the exclusion of potential reference genes from subsequent evaluation. SDHA, TBP, HPRT1 and POLR2A exhibited lower expression levels in the TCC samples and were excluded following an evaluation of the reference genes (Fig. 2) . ΔCq analysis. The remaining 14 genes had different transcript level ranges over all the specimens investigated. The present study used matched cancerous and non-cancerous TTC samples, so the Cq of the normal sample minus the Cq of the corresponding cancer sample (ΔCq) reflected the variation in the candidate reference genes between individuals (Fig. 3) . For the second criterion, a ΔCq value >1.9 was arbitrarily selected to eliminate certain candidate genes from further consideration. In accordance with this analysis, GAPDH, peptidyl-prolyl isomerase A (PPIA), transmembrane BAX inhibitor motif-containing 6 (TMBIM6), heat-shock protein 90-α family class B member 1 HSP90AB1 and S100 calcium-binding protein A6 (S100A6) were excluded from the subsequent calculations. Nevertheless, because GAPDH has been used in a number of studies, it was decided that GAPDH would be evaluated in the list of candidate reference genes. A paired Student's t-test was also used to examine differences in the expression of candidate reference genes between the matched non-malignant and malignant specimens. There were significant differences in gene expression for all of the investigated reference genes, other than β-actin (ACTB) (P=0.0763), RPS23 (P=0.0746), TPT1 (P=0.064) and RPS13 (P=0.0532). The expression of cofilin 1 (CFL1), GAPDH, S100A6, HSP90AB1, TMBIM6 and PPIA were all significantly increased in the malignant samples (P<0.001) compared with the non-malignant groups. This result was similar to that obtained for the ΔCq values.
Stability of the expression of the candidate reference genes in TCC sample
According to above analysis, 8 genes were excluded from the 18 candidate reference genes in the matched malignant and non-malignant sample pairs. The remaining 10 reference genes underwent further analysis with the mathematical software programs geNorm (11), NormFinder (12) and BestKeeper (13) .
GeNorm analysis. In view of the precondition that the ratio of the expression level of suitable reference genes must be invariable under all experimental conditions, GeNorm calculates the M-value of a single gene by gradually ruling out the highest-scoring reference gene, then repeatedly recalculating in order to obtain the optimal value.
The stability of the expression for the 10 candidate genes is ordered according to the M-value, with the lowest M corresponding to the most stably expressed genes. M=1.5 is the threshold recommended for all selected reference genes. The genes with the smallest M-value were RPS13 and RPS23 (0.58 and 0.533, respectively), which were the most stable genes in all 70 TCC and 35 non-malignant TCC samples in the present study. The order of gene stability, from the most to least stable gene was: RPS23, RPS13, TPT1, RPL13A, GAPDH, ATP synthase, H + transporting, mitochondrial F1 complex, β-polypeptide (ATP5B), CFL1, ACTB, UBC and UBB (Fig. 4A and C) . In the malignant group, RPS23 and RPS13 were still the most stable genes, with UBB and UBC again exhibiting the largest M-value. For the rest of the selected reference genes, the order of expression stability, from the most to least stable, was: TPT1, GAPDH, ACTB, CFL1, ATB5B and RPL13A (Fig. 4E) . The M-values of the ten genes were <1 in the TCC samples, below the default threshold of 1.5, suggesting a relatively high stability of expression of the selected genes (Fig. 4) .
GeNorm also offers a normalization factor for determining the optimal number of candidates by calculating the pairwise value of variation, V. For the selection of RT-qPCR reference genes, 0.2 is recommended as the threshold value. A total of 4 genes were required for good normalization in the all-TCC sample group, whereas two genes and four genes were required in the non-malignant and malignant group, respectively (Fig. 4B, D and F) .
NormFinder analysis. NormFinder is also a freely available tool for evaluating gene stability for normalization, ranking the candidate reference genes according to the output value, M. Those with the lowest M-value are considered to be the most stable reference genes. This approach combines the intergroup and intragroup expression variations of the candidate reference genes. The results calculated using NormFinder are listed in Table IV . In this analysis, RPS23 was ranked the highest in the non-malignant and malignant groups. This was unexpected, as UBC was the most stably expressed candidate gene in all the TCC samples, which was the exact opposite of the result obtained using geNorm. This discrepancy may reflect differences in the algorithm utilized. Broadly speaking, the best two-gene combination from the NormFinder program was that of ATP5B and RPS23 (M= 0.081). M values reflect gene expression stability.
BestKeeper analysis. BestKeeper is a commonly used software program that evaluates the stability of reference gene expression directly using raw Cq values. The BestKeeper index uses R to reveal gene expression variation, which is determined by calculating the coefficient of variance and standard deviation of the Cq set.
According to the BestKeeper analysis, RPS23 (R=0.967), TPT1 (R=0.964) and ATP5B (R=0.964) demonstrated the optimal associations (P<0.001 for the TCC specimens) (Table V) . ATP5B, RPS23 and TPT1 were the optimal candidate The coefficient of correlation, R, demonstrates gene expression variation, which is determined by calculating the coefficient of variance and standard deviation of the Cq set. See Table II for gene name definitions. Table II for gene name definitions. 1  ACTB  RPS23  UBC  RPS23  RPS23  2  RPS13  RPS13  UBB  TPT1  TPT1  3  RPS23  TPT1  TPT1  ATP5B  RPS13  4  TPT1  RPL13A RPS23  UBC  UBC  5  UBC  GAPDH ATP5B  GAPDH ACTB  6  UBB  ATP5B  RPL13A RPS13  ATP5B  7  ATP5B  CFL1  RPS13  RPL13A UBB  8  RPL13A ACTB  GAPDH ACTB  RPL13A  9  CFL1  UBC  ACTB  CFL1  GAPDH  10 GAPDH UBB CFL1 UBB CFL1
Cq, cycle threshold. See Table II for gene name definitions.
reference genes in the non-malignant group. TPT1, RPS23 and ACTB were the top three genes in the malignant group.
Final ranking of the selected candidate reference genes.
Considering the discrepancies among the four algorithms, a method was used to calculate the final ranking of candidate reference genes (24) . Specifically, the geometric mean for each gene was calculated using the four ranking numbers produced by ΔCq analysis (of the corresponding non-malignant and malignant samples) using geNorm, NormFinder and BestKeeper. The genes with the smallest geometric means were identified as the most stable (Table VI) . Table II for gene name definitions.
RPS23 was identified as the most stable single gene from the analysis, with RPS23, TPT1 and RPS13 being the optimal reference gene set in all the TCC samples. RPS13, RPS23 and TPT1 were also suitable reference genes for the matched non-malignant and malignant samples. The overall rank for the matched non-malignant and malignant samples is not presented, as the final ranking for all of the TCC samples illustrates this point.
Discussion
The aim of the present study was to identify the most stable reference genes to ensure credible evaluation of the transcript levels of genes of interest in human bladder cancer, specifically TCC. A total of 18 candidate reference genes were selected from a variety of databases and previous publications that investigated reference gene expression profiles (11) (12) (13) (14) (15) (16) ; these selected genes were assessed using SYBR-Green RT-qPCR in 35 pairs of matched non-malignant and malignant samples. The results of the present study demonstrate that the most stable reference gene was the rarely used RPS23, and the optimal three-gene combination, RPS23, TPT1 and RPS13, was found to be optimal for all the TCC samples, on the basis of the results of the four algorithms used.
To obtain reliable results in the RT-qPCR analysis, a concerted effort was made to ensure that each of the following criteria was met: i) All the bladder cancer samples were TCC, which is the most frequent subtype, and each sample included a malignant specimen and corresponding non-malignant specimen; ii) according to the MIQE guidelines (7), the quality and quantification of RNA and the specificity of each gene primer was strictly controlled; iii) a careful selection was carried out of 18 candidate genes from previous databases and publications reporting stable gene expression profiles (11) (12) (13) (14) (15) (16) ; and iv) three commonly used software programs, geNorm, NormFinder and BestKeeper were combined with Student's t-test and ΔCq analysis to evaluate the candidate reference genes.
To the best of our knowledge, there are two published studies on the selection of the optimal reference gene for bladder cancer, with only one having been performed using SYBR-Green (12), although it was not assessed with matched sample pairs and different mathematical algorithms. Although the other study used matched sample pairs (14 pairs), it was performed with TaqMan methods (15) . In general, the SYBR-Green method is cheaper and easier to use than TaqMan, but can lead to false-positive results owing to the presence of non-specific products, such as primer-dimers; these incorrect and shifted data may ultimately diminish the accuracy (24) . In the present study, this potential problem was controlled for by the running of agarose gels and checking the T m values to guarantee the accuracy of the unique qPCR product.
A large number of factors influence the expression level of genes in tumor tissues; these include the type, age, stage and grade of the tumor samples investigated. In the present study, the results indicate that the expression of none of the candidate reference genes was dependent on the sex, tumor stage or grade of the TCC samples. An ideal reference gene is one that is usually abundant in the studied tissues, meaning that it can be reliably measured in all of the studied materials. Thus, the Cq value of a gene was arbitrarily selected at >25 cycles for the exclusion of potential internal genes. Accordingly, SDHA, TBP, HPRT1 and POLR2A were excluded following evaluation of the reference genes in this analysis.
To compare the evaluation results, the same candidate reference genes as those selected in two published studies (12, 15) were selected. In the study by Andersen et al (12) , HSP90AB1, TMBIM6 and ATP5B were reported to be the optimal reference genes. However, TBP and SDHA were the optimal reference genes in the study by Ohl et al (15) . These genes in these two studies are not included in the results of the present study, a discrepancy that may have arisen owing to differing qPCR conditions, mathematical methods and, most importantly, TCC samples. As mentioned in the study by Ohl et al (14) , when using a greater number of matched pairs of non-cancerous and cancerous samples, the accuracy of the result was increased. Subsequently, the present study used a paired Student's t-test and 2
-ΔΔCq analysis to examine significant differences between the expression levels of the candidate reference genes in the non-malignant and malignant sample pairs. Consequently, SDHA, TBP, HPRT1, POLR2A, CFL1, S100A6, HSP90AB1, TMBIM6 and PPIA were excluded from further analysis.
The readily available software programs geNorm, NormFinder and BestKeeper were used to evaluate the optimal genes from a set of candidate reference genes (23) . Of these three programs, geNorm and NormFinder are able to provide the optimal combination of reference genes. In the case of NormFinder analysis, it is also possible to obtain the optimal single reference gene. NormFinder combines the intergroup and intragroup expression variations of the candidate reference genes, reducing the bias of the result. Unlike other algorithms, the output of BestKeeper has the capacity to analyze <10 selected reference genes. The results obtained using these programs differed somewhat, although this was generally acceptable as each program used different statistical algorithms. The more programs used, the more promising the results obtained in the evaluation of reference genes. Despite the slight discrepancies between the programs, the results from all of these algorithms indicate that RPS23 was the optimal single gene for normalization, and RPS23, TPT1 and RPS13 comprised the optimal combination of reference genes for evaluating TCC samples.
In conclusion, the results of the present study demonstrate that RPS23 was the most stably expressed reference gene, with the three most stable genes, RPS23, TPT1 and RPS13, comprising the most suitable geneset for all bladder samples. These reference genes may be used for gene normalization in studies of TCC gene expression, which are important for seeking novel molecular markers for bladder cancer in the future.
